What are the best treatments for Parkinson?

The gold standard for treating Parkinson involves a personalized combination of pharmacological therapies, such as levodopa, and targeted non-pharmacological interventions designed to manage motor symptoms and maintain quality of life.

Pharmacological Management

Levodopa (often combined with carbidopa, as in Sinemet) remains the most effective medication for managing the motor symptoms of Parkinson, such as bradykinesia and rigidity. In earlier stages or for younger patients, clinicians may prescribe dopamine agonists like pramipexole (Mirapex) or ropinirole (Requip). Additionally, monoamine oxidase type B (MAO-B) inhibitors, such as rasagiline (Azilect) or selegiline (Eldepryl), are frequently used to help sustain dopamine levels in the brain.

Non-Pharmacological and Surgical Options

Physical therapy is essential for addressing the shuffling gait and postural instability associated with Parkinson, while occupational therapy can provide strategies for managing micrographia and daily living tasks. Speech therapy, specifically Lee Silverman Voice Treatment (LSVT LOUD), is highly effective for addressing hypophonia and hypokinetic dysarthria. For patients whose symptoms become refractory to medication, deep brain stimulation (DBS) is a well-established surgical intervention that can significantly improve motor function.

The Multidisciplinary Approach

Because Parkinson affects the nervous system in complex ways, care must be individualized. A successful care team typically includes a movement disorder specialist (neurologist), a physical therapist, an occupational therapist, and a speech-language pathologist. Emerging research is currently investigating focused ultrasound and novel neuroprotective agents in various clinical trials, though these remain subject to rigorous testing.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or a qualified health provider regarding your specific Parkinson treatment plan, as medication effectiveness and side effects vary significantly between individuals.

References

• National Institute of Neurological Disorders and Stroke (NINDS/NIH)


• Orphanet: The portal for rare diseases and orphan drugs


• The Michael J. Fox Foundation for Parkinson's Research


• Genetic and Rare Diseases Information Center (GARD)